Evidence map›Paper›PMID 40516812›Full record

ArticleNeuropharmacology2025

Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption.

Brenda M Gannon, Mary E Shepard, Justin M Pressley, Hannah E Shaw, Kayla J Wolf, Marina Avram, Jeffery H Moran, William E Fantegrossi

Abstract read
In one paragraph

Article in Neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Brenda M GannonDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Graduate School, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Mary E ShepardGraduate School, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Justin M PressleyDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Graduate School, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Hannah E ShawDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Kayla J WolfDepartment of Toxicology and Cancer Biology, Forensic Toxicology and Analytical Genetics, University of Kentucky, Lexington, KY, USA.
Marina AvramGraduate School, University of Arkansas for Medical Sciences, Little Rock, AR, USA; PinPoint Testing, LLC., Little Rock, AR, USA.
Jeffery H MoranDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; PinPoint Testing, LLC., Little Rock, AR, USA.
William E FantegrossiDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Graduate School, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: WEFantegrossi@uams.edu.

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Expanding Translational Science in ArkansasUM1TR004909 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI Laura P James · 2024 to 2026
$11.7M
Translational Training in AddictionT32DA022981 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI Melissa Jean Zielinski · 2009 to 2026
$6.1M
NCATS NIH HHS UL1 TR003107NCATS NIH HHS UM1 TR004909NIDA NIH HHS T32 DA022981
6 · The paper itself

Abstract

Oral use of illicit fentanyl formulations is common, and these preparations may be contaminated with fentanyl analogs (FAs) with unknown pharmacological and toxicological properties. Route of administration impacts pharmacological effects, and pharmacokinetic or pharmacodynamic properties of oral fentanyl and FAs could influence aspects of opioid use disorder that are not necessarily present in animal models involving other routes of administration. We established oral consumption of water, or solutions of the FAs furanyl fentanyl and acryl fentanyl in C57 B l/6N mice. Consumption of pharmacologically-relevant concentrations of the FAs was reliably engendered, verified by induction of opioid-mediated antinociceptive effects in a warm-water tail withdrawal procedure, hypothermic effects, and observation of antagonist-precipitated withdrawal. When maintenance solutions were adulterated with the bitter tastant quinine, water control mice decreased their consumption, but mice consuming FA solutions defended their consumption, even at quinine concentrations that suppressed water drinking. Brief access to supplemental water, injection of the μ-opioid antagonist naltrexone, or administration of the μ-opioid agonist morphine all attenuated the defense of FA consumption. In all cases, the abuse-related effects of acryl fentanyl were greater than those of furanyl fentanyl. Consumption of acryl fentanyl also abolished weight gain across the study, and disrupted nest-building. The results of these experiments suggest that mice drinking furanyl fentanyl or acryl fentanyl experience opioid-mediated effects including antinociception, dependence and withdrawal, and abuse-related subjective effects, and provide proof of concept for use of this model to assess pharmacological and non-pharmacological manipulations which may attenuate the reinforcing effects of oral fentanyl and FAs.

Indexed as

Analgesics, OpioidFentanylFuransOpioid-Related DisordersSubstance Withdrawal SyndromeAdministration, OralAnimalsMaleMiceMice, Inbred C57BLMorphineNaltrexoneNarcotic AntagonistsQuinineAnalgesics, OpioidFentanylFuransfuranyl fentanylMorphineNaltrexoneNarcotic AntagonistsQuinine

Identifiers

PMID40516812
PMCPMC12278997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.